Gait Analysis and Gait Training in Patient With Total Hip or Total Knee Replacement (WVPT)

April 17, 2023 updated by: Federica Bressi, Campus Bio-Medico University

Gait Analysis and Gait Training in Subjects 1 Year After Total Hip or Total Knee Replacement by Means

The main objective of the present study is the evaluation of the kinematic parameters of gait and distribution of the load, recorded thruogh a sensorized treadmill, on lower limbs in patients at 1 year from Total Hip Replacement or Total Knee Replacement.

The secondary objective is to evaluate the effects of gait training with biofeedback by means of a sensorized treadmill in patients with asymmetry of the kinematic parameters of the step and of distribution of the load on the lower limbs.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • RM
      • Roma, RM, Italy, 00128
        • Recruiting
        • Rehabilitation Department - Campus Bio-Medico University
        • Contact:
        • Principal Investigator:
          • Silvia Sterzi, Full Professor
        • Principal Investigator:
          • Federica Bressi, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Mini Mental State Examination ≥ 24
  • 12 months after total hip or total knee replacement

Exclusion Criteria:

  • impossibility to perform a walking test
  • disabling cardiovascular and osteo-arthro-muscular problems that can impair walking tests
  • central or peripheral neurological disorders that compromise the sensory-motor skills of the patient under examination and / or the degree of collaboration
  • patients who have not signed informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait Speed
Time Frame: immediately after treatment
meters/second
immediately after treatment
Step Length
Time Frame: immediately after treatment
length in meters
immediately after treatment
Ground Contact Time
Time Frame: immediately after treatment
Time in seconds
immediately after treatment
Hip Kinematics
Time Frame: immediately after treatment
angles (degrees) of hip ROM
immediately after treatment
Knee Kinematics
Time Frame: immediately after treatment
angles (degrees) of knee ROM
immediately after treatment
Ankle Kinematics
Time Frame: immediately after treatment
angles (degrees) of ankle ROM
immediately after treatment
Lower limb loading
Time Frame: immediately after treatment
load percentage distribution on lower limbs
immediately after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 6, 2018

Primary Completion (Anticipated)

June 30, 2024

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

February 15, 2019

First Submitted That Met QC Criteria

February 20, 2019

First Posted (Actual)

February 21, 2019

Study Record Updates

Last Update Posted (Actual)

April 19, 2023

Last Update Submitted That Met QC Criteria

April 17, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 54/18 PAR ComEt CBM

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty, Replacement, Knee

Clinical Trials on Gait training with real time biofeedback

3
Subscribe